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Abstract
The non-extractable fraction of many fruit and vegetables contains putatively bioactive polyphenolic compounds that, in most cases, have
not been well characterised structurally. Non-extractable proanthocyanidins (NEPA) of a polymeric nature are part of the dietary fibre frac-
tion of food. Using liquid chromatography coupled to a mass spectrometer equipped with an electrospray ionisation chamber and a triple
quadrupole mass analyser for tandem analysis (HPLC–ESI–QqQ–MS/MS) techniques, we examine the phenolic metabolites present in
urine and faeces from rats 24 h after ingestion of an NEPA-rich fraction. We show that NEPA are partially depolymerised during their transit
along the intestinal tract, as evidenced by the presence of (epi)catechin (EC) monomers and dimers in faeces and phase II conjugates of EC
in urine. Moreover, NEPA are further metabolised by the intestinal microbiota into smaller metabolites including phenolic acids that are
present in urine as both free phenolics and conjugates with glucuronate or sulphate moieties. For the first time, we report evidence
that NEPA behave in vivo as a source of phenolics that are released progressively and deliver phenolic species that come into contact
with the intestinal walls and are bioavailable for at least 24 h after ingestion.
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Proanthocyanidins (PA) are a class of dietary polyphenols.
They are polymers of flavan-3-ols present in a wide variety
of plant-based foodstuffs, such as berries, cocoa or certain
nuts(1). Several supplementation studies both in animals and
in human subjects using PA-rich products have shown that
PA play a preventive role against several conditions including
CVD(2–4) or diabetes(1,5,6). Similarly, a recent epidemiological
study showed an inverse association between the intake of
polymeric PA and the risk of colorectal cancer(7). To advance
knowledge of the possible effects of PA on human health, it is
important to characterise their metabolic fate in detail, that is
to say, the degradation they may suffer once ingested and
the distribution of their metabolites through the different
organs and fluids.
Most studies of PA, including those that address their metab-
olism, assume that the PA in foodstuffs correspond exclusively
to the supernatants obtained after extracting the food with
acetone; the most common procedure for their analysis(8).
However, these PA would actually only correspond to
the extractable proanthocyanidins (EPA), which represent
only a fraction of dietary PA. Recent work has emphasised
that a considerable proportion of PA, the non-extractable
proanthocyanidins (NEPA), remains in the residue from such
extractions(9) and may very well play a more significant
functional role than EPA. NEPA are associated with other com-
ponents of the food matrix, mainly dietary fibre, and in fact
constitute a part of it, according to current definitions of diet-
ary fibre(10,11). To date, there is no common method for deter-
mining NEPA. They are usually determined by destructive
spectrophotometric methods and only a few recent papers
have attempted structurally meaningful analysis(12,13); there-
fore, structural evidence regarding the composition of NEPA
as essential constituents of many foodstuffs is still scarce.
The currently available evidence suggests that NEPA may be
more abundant than EPA in much food(12–14) and, therefore,
that significant amounts of NEPA are ingested daily.
Over the last decade, several studies have addressed the
metabolism of PA. Although initial studies emphasised fairly
poor intestinal absorption that was limited to dimers(15–17),
later observations indicate that once intact PA reach the
colon they are widely transformed by the colonic microbiota
into small phenolic acids(18–21). These metabolites are
absorbed, and then transformed in the liver, and the resulting
conjugates are transferred to the bloodstream. A recent study
*Corresponding author: Dr J. Pe´rez-Jime´nez, fax þ34 93 204 59 04, email jara.perez@iqac.csic.es
Abbreviations: EC, (epi)catechin; EPA, extractable proanthocyanidins; GADF, grape antioxidant dietary fibre; GlcA, glucuronide; MRM, multiple reaction
monitoring; NEPA, non-extractable proanthocyanidins; PA, proanthocyanidins; ppm, parts per million.
British Journal of Nutrition (2012), 108, 290–297 doi:10.1017/S0007114511005678
q The Authors 2011
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
in which [14C]procyanidin B2, a labelled PA dimer, was admi-
nistered to rats, reported bioavailability of around 80 %, based
on total urinary 14C(20).
Nevertheless, these papers have mostly addressed the bio-
availability of dimers or trimers, while the most abundant PA
in food are polymers(22). Indeed, some recent studies have
suggested that PA are also depolymerised into (epi)catechin
(EC) units before cleavage into smaller species and further
metabolism(21,23–25). These studies suggest that phenolics
that are bioavailable after the ingestion of PA-rich foodstuffs
must have come from NEPA(24–26), but this has not been
proved as the specific metabolism of NEPA has never been
reported.
Grape antioxidant dietary fibre (GADF) is a food product
obtained from red grapes that is rich in dietary fibre and poly-
phenols(27). Besides extractable polyphenols, including
EPA(28), GADF contains a significant amount (14·8 %) of
NEPA(27) and was used in the studies which suggest that
non-extractable polyphenols are an important source of
metabolites that are bioavailable in rats(24–26). To study the
contribution of NEPA to the pool of phenolic metabolites
from fruit and vegetables, we considered using a NEPA-rich
fraction from GADF.
Our objective was to evaluate the fate of NEPA in rats 24 h
after ingestion of a preparation free from any extractable poly-
phenols. NEPA metabolites, including hepatic and microbially
derived metabolites, were analysed in urine and faeces using
liquid chromatography coupled to a mass spectrometer
equipped with an electrospray ionisation (ESI) chamber and
a triple quadrupole mass analyser for tandem analysis
(HPLC–ESI–QqQ–MS/MS).
Experimental methods
Reagents and samples
GADF was obtained from red grapes (Cencibel variety, har-
vested in 2005 in La Mancha region of Spain) by a patented
procedure(29). The NEPA content of GADF has previously
been reported to be 14·8 g/100 g of dry weight(27). To obtain
an EPA-free (and therefore NEPA-rich) fraction, GADF (4 g)
was defatted with hexane (3 £ 40 ml), air-dried overnight
and the residue was extracted with methanol–water (50:50,
v/v, 200 ml) and then with acetone–water–acetic acid
(70:29·5:0·5, by vol., 200 ml) once each at room temperature.
The supernatant was decanted and the residue, including
the NEPA-rich fraction, was vacuum filtered and lyophilised.
The actual NEPA content of this residue is around 25 % accord-
ing to published information(26).
Standards of EC ($97 %), 3- and 4-hydroxyphenylacetic
acid ($98 %), 3,4-dihydroxyphenylacetic acid ($98 %),
3- and 4-hydroxybenzoic acid ($97%), vanillic acid ($97%),
caffeic acid ($95 %), 3,4-di-hydroxyphenylpropionic acid
($98 %), 4-hydroxyphenylpropionic acid (.98 %), protocate-
chuic acid ($97 %), ferulic acid ($99 %), isoferulic acid
($97 %), p-coumaric acid ($98 %), m-coumaric acid
($97 %) and taxifolin ($85 %) were obtained from Sigma
Chemical (St Louis, MO, USA). Methanol (analytical grade),
phosphoric acid ($85 %) and acetic acid were purchased
from Panreac (Castellar del Valle`s, Barcelona, Spain).
Acetonitrile (HPLC grade) and formic acid (analytical grade)
were obtained from Merck (Darmstadt, Germany). Water
was purified by a Milli-Q plus system from Millipore (Bedford,
MA, USA) to a resistivity of 18·2 mV/cm.
Animal experiments
The study was carried out on female Sprague–Dawley rats
(n 10, body weight 233 (SD 9·3) g, 12 weeks of age) provided
by Harlan Interfauna Ibe´rica SL (Barcelona, Spain). The
animals were fed with a polyphenol-free diet (TD94048),
also purchased from Harlan Interfauna Ibe´rica SL, and they
were maintained in plastic cages at room temperature
(22 ^ 28C) and 55 (SD 10) % relative humidity, with a 12 h
light–12 h dark cycle for 1 week, in accordance with Euro-
pean Union regulations. After food deprivation for 12 h with
free access to water, a group of animals (n 5) was adminis-
tered a suspension of NEPA from GADF in tap water (1 g
NEPA-rich fraction/10 ml, 1·6 g NEPA-rich fraction/kg body
weight) by oral gavage, while a control group (n 5) was admi-
nistered tap water (16 ml/kg body weight). The animals were
then placed in metabolism cages and urine and faeces were
collected over 24 h and stored at 2808C until extraction and
analysis. These experimental protocols were approved by
the Experimental Animal Ethical Research Committee of the
CSIC in accordance with the current regulations for the use
and handling of experimental animals.
Sample preparation
The biological samples were prepared according to pre-
viously described procedures for the extraction of phenolic
metabolites(21,24,25). Briefly, urine samples were concentrated
via a nitrogen stream at room temperature and then resus-
pended in 1 ml of acid water (addition of phosphoric acid
to reach pH 3). Taxifolin (100ml of a 50 parts per million
(ppm) solution) was added as an internal standard, to
obtain a final concentration of 5 ppm. Then the samples
were subjected to solid phase extraction in Oasis HLB
(60 mg) cartridges from Waters Corporation (Mildford, MA,
USA). The cartridges were activated with methanol (1 ml)
and acid water (2 ml) and the samples loaded. To remove
interfering components, the samples were washed with acid
water (9 ml) and then the phenolic compounds were eluted
with methanol (1 ml).
Faeces (0·5 g) were defatted with hexane (10 ml) and the
residue was extracted with methanol–water–phosphoric
acid (8:1·9:0·1, by vol., 10 ml) and concentrated down to
1 ml by nitrogen stream at room temperature. Taxifolin
(100ml of a 50 ppm solution, final concentration 5 ppm) was
added to each sample as an internal standard.
Extracts from both urine and faeces were filtered through
a polytetrafluoroethylene 0·45-mm membrane from Waters
Corporation into amber vials for HPLC–MS/MS analysis.
Fate of non-extractable proanthocyanidins 291
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
HPLC–electrospray ionisation–MS/MS analysis
A Quatro LC from Waters Corporation triple quadrupole mass
spectrometer with an electrospray source was used in negative
mode to obtain MS and MS/MS data. Liquid chromatography
separations were performed using an Alliance 2695 system
from Waters Corporation equipped with a Phenomenex
(Torrance, CA, USA) Luna C18 (50 £ 2·1 mm internal dia-
meter) 3·5mm particle size column and a Phenomenex
Securityguard C18 (4 £ 3 mm internal diameter) column. Gra-
dient elution was performed with a binary system consisting
of (A) 0·1 % aqueous formic acid and (B) 0·1 % formic acid
in CH3CN. An increasing linear gradient (v/v) was used
(t (min), %B): 0, 8; 10, 23; 15, 50; 20, 50; 21, 100, followed
by a re-equilibration step.
Metabolites were detected in multiple reaction monitoring
(MRM) experiments, and their identity was confirmed by
product ion scan experiments. The dwell time for the MRM
experiments was 100 ms and the cycle time for all the experi-
ments was 2 s. Cone energy and collision energy in MRM
mode were optimised for each group of metabolites: 30 V
and 10 eV for taxifolin, 30 V and 15 eV for microbially derived
phenolic metabolite derivatives, 30 V and 20 eV for EC, and
40 V and 20 eV for EC derivatives.
Results
(Epi)catechin and its phase II metabolites
Free EC (MRM transition 289! 245) and a signal correspond-
ing to a dimer (577! 289) were detected in faeces by liquid
chromatography–ESI–MS/MS. The product ion spectrum of
this dimer provided characteristic fragments at m/z 425 and
m/z 405 originated by cleavage of the C-ring of one of the
EC units through a retro Diels–Alder reaction and consecutive
loss of water. A fragment at m/z 451, caused by heterolytic
ring fission, was also observed.
A total of ten EC conjugates derived from the activity of
phase-II enzymes in both the intestinal tract and liver were
detected in urine samples (Table 1). All these compounds
were either not detected in the control group or detected at
concentrations that were at least 10-fold lower. The metab-
olites were initially identified by previously reported MRM
transitions corresponding to the main fragments(24,30) and
their identity was confirmed by a second MRM transition
and/or by product ion scan experiments.
The EC metabolites included three glucuronidated forms
(465! 289), two sulphated forms (369! 289), a monoconju-
gated metabolite with glutathione (594! 289), two methylated
and glucuronidated forms (479! 303), a di-glucuronidated
form (641! 289) and a tri-conjugated metabolite (397! 289)
corroborated by MS/MS experiments. All these derivatives
were detected in urine samples and the di-glucuronidated
conjugate was also detected in faeces.
Fig. 1 shows the product ion spectrum of glucuronide (GlcA)-
EC-3 (m/z 465). Fragments at m/z 289 and m/z 245, correspond-
ing to the loss of the conjugate moiety and the respective
cleavage of CO2 from the free EC unit, were observed; as were
two fragments at m/z 175 and 113, from the fragmentation of
the GlcA moiety. The MS/MS spectra of other conjugates
showed characteristic fragments corresponding to a B-ring
retro Diels-Alder fission of the EC, such as the fragment at m/z
137 for Me-GlcA-EC, which corresponds to a B-ring fragment
with attached methyl group and GlcA moieties, indicating that
the conjugation was located on the B-ring.
Microbially derived proanthocyanidin metabolites
A total of twenty microbially derived PA metabolites were
identified in urine from rats fed the NEPA-rich fraction; two
of them were also detected in faeces (Table 2). All these
metabolites were either not detected in the control group or
detected at concentrations that were at least 10-fold lower.
Microbially derived PA metabolites detected in urine included
valerolactones, phenylvaleric acids, phenylpropionic acids,
phenylacetic acids, benzoic acid, cinnamic acids and lignans.
3,4-Dihydroxyphenylacetic acid, detected by MRM transition
(167! 123), has been reported to be as a specific metabolite
of polymeric PA, since it has never been identified in
studies performed with pure monomeric flavan-3-ols(31).
3,4-Dihydroxyphenylacetic acid may be metabolised to
Table 1. (2 )-(Epi)catechin (EC) and conjugated metabolites in urine and faeces from rats fed a non-extractable
proanthocyanidin-rich fraction from grape antioxidant dietary fibre
Metabolite MRM parent Identification Urine Faeces
(–)-EC 289 ! 245 Standard retention time £
PC dimer 577 ! 289 MS/MS: 575; 451; 424; 405; 327; 289; 123 £
Mono-conjugated metabolites
GlcA-EC-1 465 ! 289 MS/MS: 465; 289; 245; 137; 113 £
GlcA-EC-2 465 ! 289 MS/MS: 465; 289; 257; 175;113 £
GlcA-EC-3 465 ! 289 MS/MS: 465; 289; 245; 175; 113 £
Sulf-EC-1 369 ! 289 MS/MS: 369; 289; 245; 228; 184; 113 £
Sulf-EC-2 369 ! 289 MRM daughter 289 ! 245 £
GSH-EC-1 594 ! 289 MRM daughter 289 ! 245 £
Di-conjugated metabolites
Me-GlcA-EC-1 479 ! 303 MS/MS: 479; 303; 289; 245; 173; 137; 113 £
Me-GlcA-EC-2 479 ! 303 MS/MS: 479; 303; 285; 259; 173; 137; 113 £
Di-GlcA-EC-1 641 ! 289 MS/MS: 641; 465; 289 £ £
Tri-conjugated metabolites
Di-Me-Sulf-EC-1 397 ! 289 MRM daughter 289 ! 245 £
MRM, multiple reaction monitoring; PC, procyanidins; GlcA, glucuronide; Sulf, sulphate; GSH, glutathione; Me: methyl group.
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3-hydroxyphenylacetic acid and 4-hydroxyphenylacetic acid
(151! 107), which were also detected. Similarly, 3,4-dihy-
droxyphenylpropionic acid, 3-hydroxyphenylpropionic acid
and 4-hydroxyphenylpropionic acid were detected in
urine. Both 3,4-dihydroxyphenylacetic acid and 3,4-dihydrox-
yphenylpropionic acid were absorbed and later conjugated
in the liver as shown by the detection of the derivatives
GlcA-3 or 4-hydroxyphenylacetic acid (327! 151), Sulf-3,
4-dihydroxyphenylpropionic acid (261! 181) and Sulf-
3 or 4-hydroxyphenylpropionic acid (245! 165). Conjugated
forms of phenylvaleric and hippuric acid were detected
in urine.
Two microbially derived phenolic metabolites were ident-
ified in the faeces from rats fed the NEPA-rich fraction:
4-hydroxyphenylpropionic acid (165! 121) and 3,4-dihy-
droxyphenylpropionic acid (181! 137).
Phenolic acids generated fragments corresponding to the
successive loss of two CO2 molecules. Similarly, MS/MS spec-
tra of sulphated forms showed signals corresponding to the
loss of sulphate and CO2. These fragments confirm the identity
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Fig. 1. HPLC–electrospray ionization-MS/MS product ion scan spectrum of glucuronide-(epi)catechin (m/z 465). cps, Counts per second; amu, atomic mass unit;
max., maximum.
Table 2. Detection of microbially derived proanthocyanidin metabolites in urine and faeces from rats fed a non-
extractable proanthocyanidin-rich fraction from grape antioxidant dietary fibre
Metabolite MRM parent Identification Urine Faeces
Valerolactones
Sulf-dihydroxyphenylvalerolactone 287 ! 207 MRM daughter 207 ! 163 £
Phenylvaleric acids
Sulf-dihydroxyphenylvaleric acid 289 ! 209 MRM daughter 209 ! 165 £
Phenylpropionic acids
4-Hydroxyphenylpropionic acid 165 ! 121 MS/MS: 165; 121; 93 £ £
3,4-Dihydroxyphenylpropionic acid 181 ! 137 Standard retention time £ £
Sulf-3,4-dihydroxyphenylpropionic acid 261 ! 181 MRM daughter 181 ! 137 £
Suf-3 or 4-hydroxyphenylpropionic acid 245 ! 165 MS/MS: 245; 165; 121 £
Phenylacetic acids
3-Hydroxyphenylacetic acid 151 ! 107 Standard retention time £
4-Hydroxyphenylacetic acid 151 ! 107 Standard retention time £
GlcA- 3- or 4-hydroxyphenylacetic acid 327 ! 151 MS/MS: 327; 151; 107 £
3,4-Dihydroxyphenylacetic acid 167 ! 123 MS/MS: 167; 123; 105; 95 £
Benzoic acids
Benzoic acid 121 ! 77 Standard retention time £
4-Hydroxybenzoic acid 137 ! 93 Standard retention time £
3,4-Dihidroxybenzoic acid 153 ! 109 Standard retention time £
Hippuric acid 178 ! 134 Standard retention time £
Me-hippuric acid 193 ! 178 MS/MS: 193; 178; 134 £
Cinnamic acids
m-Coumaric acid 163 ! 119 Standard retention time £
p-Coumaric acid 163 ! 119 Standard retention time £
Ferulic acid 193 ! 134 Standard retention time £
Lignans
Enterodiol 301 ! 107 Standard retention time £
Sulf-enterolactone 377 ! 297 MRM daughter 297 ! 253 £
MRM, multiple reaction monitoring; Sulf, sulphate; GlcA, glucuronide; Me, methyl group.
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of some of the microbially derived metabolites; others were
confirmed by the use of standards, i.e. 4-hydroxybenzoic
acid (Fig. 2).
Discussion
Several studies have addressed the metabolism of dietary oli-
gomeric PA, mostly dimers. That work provides quite a clear
picture of the different steps in the metabolism of PA dimers
in laboratory animals and human subjects(18–21). This process
comprises the absorption of monomers and small oligomers
(dimers) of PA in the small intestine and the absorption of
microbially derived metabolites in the large intestine, after
direct fermentation of the oligomers by microbiota without
prior depolymerisation into EC. The absorbed metabolites
may be conjugated in the liver, mostly resulting in GlcA,
sulphates and methyl derivatives which pass to the blood-
stream and eventually reach other tissues. Finally, the metab-
olites are excreted in urine and the fraction of PA that is not
absorbed is excreted in faeces.
The metabolic fate of larger PA polymers is believed to
follow the same pattern as that of dimers and trimers: essen-
tially, direct cleavage of the EC units into smaller phenolic
acids by the intestinal microbiota. By examining the metabolic
fate of GADF, we have recently suggested that polymeric PA
undergo depolymerisation into EC units during their transit
along the intestinal tract(24,25). This is important because it
implies that the polymers may gradually release EC moieties
during the postprandial period. Using a NEPA-rich fraction,
devoid of EC monomers and extractable oligomers, we
show here that this is indeed occurring. The faeces of rats
fed with NEPA contained monomeric and dimeric EC and
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Fig. 2. HPLC–electrospray ionisation-MS profile corresponding to the detection by multiple reaction monitoring of 4-hydroxybenzoic acid (transition 137 ! 93):
(a) urine from rats fed non-extractable proanthocyanidins from grape antioxidant dietary fibre, (b) 4-hydroxybenzoic acid standard, (c) urine from rats fed water.
M. L. Mateos-Martı´n et al.294
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
their urine contained 10 phase II EC metabolites. These results
clearly show that this fraction of dietary fibre generates bioa-
vailable derivatives of EC. The di-glucuronidated EC derivative
detected in faeces further demonstrates that those monomers
that are released from NEPA efficiently enough to reach the
liver suffer conjugation and are transported back to the intes-
tine via bile. Our evidence for intestinal depolymerisation is
consistent with a recent observation by Jove´ et al.(32) who
report a 600 % recovery of free EC in the caecal content of
rats after providing them with a single dose of PA-rich
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Fig. 3. Metabolism of non-extractable proanthocyanidins (NEPA).
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almond extract. Moreover, the more than twenty EC-derived
smaller metabolites detected in urine are consistent with the
previous description of microbial fermentation and absorp-
tion. Our results also corroborate NEPA as PA, since direct evi-
dence of the structure of these insoluble polymers is scarce. In
fact, the residue after extraction with 70 % acetone is com-
monly not considered to be a source of polyphenols. Our
results agree with those which report that the residues of
the common extraction with 70 % acetone contain significant
amounts of PA(12–14).
The transformation of NEPA (Fig. 3) differs in part from the
process suggested for the transformation of small EPA, pre-
viously described. In the case of NEPA, a proportion of the
larger PA polymers appears to be depolymerised during their
transit along the intestinal tract, resulting in delivery of EC
monomers and possibly oligomers. The posterior degradation
by the intestinal microbiota into small units may also differ
between NEPA and EPA. As NEPA are associated with the
food matrix in foodstuffs, particularly with other insoluble
polymers constitutive of dietary fibre, their conversion may
be slow compared to that of EPA. This deferred release
would make NEPA metabolites bioavailable for particularly
long times after intake and may result in them having health
effects for a long time. This may explain the previously
reported delay in the increase of plasma antioxidant capacity
after the intake of GADF by human subjects compared to
that observed after the intake of food rich in EPA, such as
red wine(33). In addition, the metabolites detected in faeces
prove that putatively active species remain in contact with
the colonic epithelium for at least 24 h after ingestion.
Indeed, the intake of PA, and particularly PA with a high
degree of polymerisation, has been associated with a reduced
risk of colorectal cancer(7) and our results suggest that
food sources of NEPA could provide such putative cancer-
preventative PA.
Previous nutritional studies have considered the extractable
fraction of PA as the only source of dietary polyphenols. We
show here that NEPA should be taken into account as most
of the food in these studies contains significant amounts of
NEPA. Further work is needed, both on the systematic analysis
of NEPA in foodstuffs and on the metabolism of NEPA from
different food sources, in order to unravel the contribution
of this fraction of dietary PA to the health-promoting effects
of fruit and vegetables.
In conclusion, we show here that NEPA are a source of
polymeric PA that are progressively depolymerised during
their transit along the intestinal tract into EC monomers and
dimers, and later metabolised by the intestinal microbiota
into smaller units. As a result, EC, phenolic acids and their
phase II metabolites are in contact with the intestinal tract
and bioavailable for at least 24 h after ingestion.
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